Drug Shortage Report for LABETALOL HYDROCHLORIDE INJECTION, USP

Last updated on 2019-03-09 History
Report ID 10718
Drug Identification Number 02387468
Brand name LABETALOL HYDROCHLORIDE INJECTION, USP
Common or Proper name LABETALOL HYDROCHLORIDE INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) LABETALOL HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20ML 1VL
ATC code C07AG
ATC description BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-05-01
Actual start date 2018-05-05
Estimated end date Unknown
Actual end date 2019-03-08
Shortage status Resolved
Updated date 2019-03-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2017-08-01 English Compare
v13 2017-07-25 French Compare
v12 2017-07-25 English Compare
v11 2017-07-18 French Compare
v10 2017-07-18 English Compare
v9 2017-07-08 English Compare
v8 2017-07-07 French Compare
v7 2017-07-07 English Compare
v6 2017-07-07 English Compare
v5 2017-07-07 English Compare
v4 2017-06-11 English Compare
v3 2017-05-19 French Compare
v2 2017-05-19 English Compare
v1 2017-05-19 English Compare

Showing 21 to 34 of 34